▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Prosper Junior Bakiny

TMFPBakiny

Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.

Recent Articles by Prosper Junior Bakiny

Person packing shipping boxes

Aug 18, 2025 by Prosper Junior Bakiny

Prediction: These 2 Stocks Will Outperform the Market in the Next Decade

Investing in market leaders is a great way to earn superior returns over the long run.

Patient talking with a physician.

Aug 18, 2025 by Prosper Junior Bakiny

If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today

You'd be sitting pretty right now.

Businessperson and doctor talking.

Aug 17, 2025 by Prosper Junior Bakiny

Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm

These companies have successfully navigated similar obstacles before.

scientist altering DNA genome project

Aug 17, 2025 by Prosper Junior Bakiny

Here's How This Forgotten Healthcare Stock Could Generate Life-Changing Returns

This biotech's innovative approach could pay rich dividends down the road.

Pharmacist talking to patient

Aug 17, 2025 by Prosper Junior Bakiny

1 Stock Down 40% This Year to Buy and Hold

This might be a wonderful entry point for long-term investors.

Physicians in an operating room

Aug 17, 2025 by Prosper Junior Bakiny

If You're in Your 30s, Consider Buying These 2 Healthcare Stocks

Both companies have helped pioneer important medical breakthroughs.

Patient taking medicine.

Aug 17, 2025 by Prosper Junior Bakiny

1 Beaten-Down Stock That Could Soar by the End of the Year

The drugmaker has a major catalyst on the way.

Patient self-administering a shot

Aug 17, 2025 by Prosper Junior Bakiny

This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors

The drugmaker's recent dip could also be a buying opportunity.

Physician giving medicine to elderly patient.

Aug 16, 2025 by Prosper Junior Bakiny

2 Top Dividend Stocks to Buy on the Dip

These blue chip healthcare stocks could still deliver strong long-term returns.

Person paying with a smartphone.

Aug 16, 2025 by Prosper Junior Bakiny

2 Stocks to Buy on the Dip and Hold for 10 Years

There should be plenty of long-term upside for these stocks for investors willing to ride out the storm.

Physician giving medicine to elderly patient.

Aug 15, 2025 by Prosper Junior Bakiny

Is This Beaten-Down Stock a Buy on the Dip?

It's the second time this year the stock has slumped significantly in one day, and it might represent another attractive entry point.

Physician talking to patient.

Aug 15, 2025 by Prosper Junior Bakiny

2 Growth Stocks That Are No-Brainer Buys Right Now

These stocks have outperformed broader equities over the past decade and still have room to run.

Person sitting and working at a desk.

Aug 15, 2025 by Prosper Junior Bakiny

2 Dividend Stocks to Buy and Hold

These stocks look like they can weather almost any storm.

Person making a trade on a stock trading app

Aug 15, 2025 by Prosper Junior Bakiny

This Cathie Wood Stock Has More Than Doubled This Year, and It's Not Too Late to Buy

This is quite the turnaround story.

Person working at a desk.

Aug 13, 2025 by Prosper Junior Bakiny

2 Top Stocks to Invest $1,000 in Right Now

These stocks continue to beat expectations.

Patient on a telehealth consultation.

Aug 13, 2025 by Prosper Junior Bakiny

2 Stocks Down More Than 90% That Still Aren't Worth Buying

There's still considerable downside risk for these beaten-down companies.

scientist altering DNA genome project

Aug 12, 2025 by Prosper Junior Bakiny

Can This Beaten-Down Stock Bounce Back?

This small-cap biotech is seeking to develop breakthrough therapies, but so far it's found little success.

Person packing shipping boxes

Aug 11, 2025 by Prosper Junior Bakiny

The Smartest Growth Stock to Buy With $160 Right Now

This stock has outperformed the market over the past decade, but there might be more upside ahead.

Pharmacist talking to patient

Aug 11, 2025 by Prosper Junior Bakiny

Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?

It was a rare breath of fresh air for shareholders.

Couple watching TV

Aug 11, 2025 by Prosper Junior Bakiny

2 Stocks That Have More Than Doubled in the Past Year and Still Have Room to Run

These companies are proving the doubters wrong in a big way.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services